|Bid||0.2000 x 0|
|Ask||0.2300 x 0|
|Day's range||0.2200 - 0.2350|
|52-week range||0.1600 - 0.6000|
|Beta (3Y monthly)||0.10|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
A look at the shareholders of Anatara Lifesciences Limited (ASX:ANR) can tell us which group is most powerful...
Anatara Lifesciences Limited (ASX:ANR) shareholders should be happy to see the share price up 22% in the last month...
Attractive stocks have exceptional fundamentals. In the case of Anatara Lifesciences Limited (ASX:ANR), there's is a...
Anatara Lifesciences Limited's (ASX:ANR): Anatara Lifesciences Limited engages in the development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. The company...
Anatara Lifesciences Limited (ASX:ANR), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is ANRRead More...
Anatara Lifesciences Limited (ASX:ANR) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of Read More...